植入式心臟整流去顫器(ICD)的開發平台 - 開發階段，市場區隔，地區和國家，法規途徑，主要企業(2023年版)

Implantable Cardioverter Defibrillators (ICD) Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

出版日期: 2023年04月19日 | 出版商:

GlobalData | 英文 85 Pages | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

本報告提供植入式心臟整流去顫器(ICD)的開發中產品調查分析，包含各開發階段產品的比較分析，及進行中的臨床試驗相關之全面性資訊。

植入式心臟整流去顫器(ICD) - 開發中產品:各開發階段
植入式心臟整流去顫器(ICD) - 開發中產品:各市場區隔
植入式心臟整流去顫器(ICD) - 開發中產品:各地區
植入式心臟整流去顫器(ICD) - 開發中產品:各法規途徑
植入式心臟整流去顫器(ICD) - 開發中產品:估計核准日
植入式心臟整流去顫器(ICD) - 進行中的臨床試驗

第4章植入式心臟整流去顫器(ICD) - 正在開發的開發中產品:各企業

植入式心臟整流去顫器(ICD)企業 - 開發中產品:各開發階段
植入式心臟整流去顫器(ICD) - 開發中產品:各開發階段

第5章植入式心臟整流去顫器(ICD)的企業和產品概要

Advanced BioInformatics GmbH:企業概要
- Advanced BioInformatics GmbH:開發中產品和進行中的臨床試驗概要
AIS Inc.:企業概要
- AIS Inc.:開發中產品和進行中的臨床試驗概要
Arrhythmia Dynamics LLC:企業概要
- Arrhythmia Dynamics LLC:開發中產品和進行中的臨床試驗概要
AtaCor Medical Inc:企業概要
- AtaCor Medical Inc:開發中產品和進行中的臨床試驗概要
Boston Scientific Corp:企業概要
- Boston Scientific Corp:開發中產品和進行中的臨床試驗概要
CardiaLen, Inc.:企業概要
- CardiaLen, Inc.:開發中產品和進行中的臨床試驗概要
Coridea, LLC:企業概要
- Coridea, LLC:開發中產品和進行中的臨床試驗概要
Impulse Dynamics Germany GmbH:企業概要
- Impulse Dynamics Germany GmbH:開發中產品和進行中的臨床試驗概要
InnerPulse Inc(暫停中):企業概要
- InnerPulse Inc(暫停中):開發中產品和進行中的臨床試驗概要
Johns Hopkins University:企業概要
- Johns Hopkins University:開發中產品和進行中的臨床試驗概要
Kenergy Inc.:企業概要
- Kenergy Inc.:開發中產品和進行中的臨床試驗概要
Massachusetts General Hospital:企業概要
- Massachusetts General Hospital:開發中產品和進行中的臨床試驗概要
Max Planck Institute for Dynamics and Self-Organization:企業概要
- Max Planck Institute for Dynamics and Self-Organization:開發中產品和進行中的臨床試驗概要
Medicool Technologies Inc:企業概要
- Medicool Technologies Inc:開發中產品和進行中的臨床試驗概要
Medtronic Inc:企業概要
- Medtronic Inc:開發中產品和進行中的臨床試驗概要
Medtronic Plc:企業概要
- Medtronic Plc:開發中產品和進行中的臨床試驗概要
MicroPort CRM SA:企業概要
- MicroPort CRM SA:開發中產品和進行中的臨床試驗概要
MicroPort Scientific Corp:企業概要
- MicroPort Scientific Corp:開發中產品和進行中的臨床試驗概要
Smartwave Medical Ltd(暫停中):企業概要
- Smartwave Medical Ltd(暫停中):開發中產品和進行中的臨床試驗概要
University of Chicago:企業概要
- University of Chicago:開發中產品和進行中的臨床試驗概要

第6章植入式心臟整流去顫器(ICD) - 最近的開發

第7章附錄

簡介目錄

Product Code: GDME1522EPD

Abstract

GlobalData's Medical Devices sector report, "Implantable Cardioverter Defibrillators (ICD) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Implantable Cardioverter Defibrillators (ICD) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart's rhythm and delivers electric pulses if it detects an arrhythmia (irregular heartbeat) to restore the heart's natural rhythm.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Implantable Cardioverter Defibrillators (ICD) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Implantable Cardioverter Defibrillators (ICD) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Implantable Cardioverter Defibrillators (ICD) Overview

3 Products under Development

3.1 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
3.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
3.3 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
3.4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
3.5 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
3.6 Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials

4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products under Development by Companies

4.1 Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development
4.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development

5 Implantable Cardioverter Defibrillators (ICD) Companies and Product Overview

5.1 Advanced BioInformatics GmbH Company Overview
- 5.1.1 Advanced BioInformatics GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.2 AIS Inc. Company Overview
- 5.2.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Arrhythmia Dynamics LLC Company Overview
- 5.3.1 Arrhythmia Dynamics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 AtaCor Medical Inc Company Overview
- 5.4.1 AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Boston Scientific Corp Company Overview
- 5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.6 CardiaLen, Inc. Company Overview
- 5.6.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.7 Coridea, LLC Company Overview
- 5.7.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.8 Impulse Dynamics Germany GmbH Company Overview
- 5.8.1 Impulse Dynamics Germany GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.9 InnerPulse Inc (Inactive) Company Overview
- 5.9.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.10 Johns Hopkins University Company Overview
- 5.10.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.11 Kenergy Inc. Company Overview
- 5.11.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.12 Massachusetts General Hospital Company Overview
- 5.12.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.13 Max Planck Institute for Dynamics and Self-Organization Company Overview
- 5.13.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview
5.14 Medicool Technologies Inc Company Overview
- 5.14.1 Medicool Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Medtronic Inc Company Overview
- 5.15.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Medtronic Plc Company Overview
- 5.16.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.17 MicroPort CRM SA Company Overview
- 5.17.1 MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview
5.18 MicroPort Scientific Corp Company Overview
- 5.18.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.19 Smartwave Medical Ltd (Inactive) Company Overview
- 5.19.1 Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.20 University of Chicago Company Overview
- 5.20.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview

6 Implantable Cardioverter Defibrillators (ICD)- Recent Developments

6.1 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
6.2 Feb 08, 2023: Nihon Kohden Announces Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2023
6.3 Feb 07, 2023: JMS Co Announces Financial Results for the 3rd Quarter of FYE March 2023
6.4 Feb 01, 2023: Japan Lifeline Announces Consolidated Financial Results for the Nine months Ended December 31, 2022
6.5 Jan 31, 2023: Fukuda Denshi Announces Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023
6.6 Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president
6.7 Jan 30, 2023: Philips to lay off 6,000 employees in drive to improve profitability
6.8 Nov 23, 2022: Medtronic Reports Quarterly Earnings
6.9 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
6.10 Nov 17, 2022: Mindray North America unveils new true to life vital signs monitor
6.11 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
6.12 Nov 09, 2022: Nihon Kohden Consolidated Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2023
6.13 Nov 04, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended September 2022
6.14 Oct 31, 2022: Fukuda Denshi Financial Results for the Second Quarter of the Fiscal Year Ending March 2023
6.15 Oct 31, 2022: Fukuda Denshi Notice of the Revision Forecast of the Financial Results, Distribution of Surplus and Year-end Dividend Forecast, Stock Split
6.16 Oct 24, 2022: Philips To Cut 4000 Jobs As Company Faces Multiple Challenges
6.17 Oct 19, 2022: Nihon Kohden Announces a Revision to its Forecast for Financial Results
6.18 Oct 12, 2022: Philips provides update on its financial performance in Q3 2022
6.19 Sep 07, 2022: Medtronic to appear at September investor conferences
6.20 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
6.21 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
6.22 Aug 18, 2022: Philips to convene Extraordinary General Meeting of Shareholders to appoint Roy Jakobs as new President and Chief Executive Officer
6.23 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
6.24 Aug 05, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended June 2022
6.25 Jun 28, 2022: Japan Lifeline Co. Notice of Resolution of the 42nd Annual General Meeting of Shareholders
6.26 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
6.27 May 31, 2022: CONMED Announces Private Offering of $600 Million of Convertible Senior Notes
6.28 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
6.29 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
6.30 May 13, 2022: Nihon Kohden Consolidated Financial Results for the Fiscal Year Ended March 31, 2022
6.31 May 13, 2022: Nihon Kohden announces FY2021 consolidated financial results
6.32 May 04, 2022: Conmed Announces First Quarter 2022 Financial Results
6.33 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
6.34 Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022